Hongfei Chen - Search Results

Year	Number of Results
2008	1
2010	3
2011	3
2012	3
2014	2
2015	4
2016	4
2017	5
2018	11
2019	4
2020	5
2021	11
2022	19
2023	17
2024	9

1

MitoQ alleviates LPS-mediated acute lung injury through regulating Nrf2/Drp1 pathway.

Hou L, Zhang J, Liu Y, Fang H, Liao L, Wang Z, Yuan J, Wang X, Sun J, Tang B, Chen H, Ye P, Ding Z, Lu H, Wang Y, Wang X. Hou L, et al. Among authors: chen h. Free Radic Biol Med. 2021 Mar;165:219-228. doi: 10.1016/j.freeradbiomed.2021.01.045. Epub 2021 Feb 1. Free Radic Biol Med. 2021. PMID: 33539948

2

Recent Advances of Curcumin Derivatives in Breast Cancer.

Yin Y, Tan Y, Wei X, Li X, Chen H, Yang Z, Tang G, Yao X, Mi P, Zheng X. Yin Y, et al. Among authors: chen h. Chem Biodivers. 2022 Oct;19(10):e202200485. doi: 10.1002/cbdv.202200485. Epub 2022 Sep 26. Chem Biodivers. 2022. PMID: 36069208 Review.

3

Structure and Anti-HIV Activity of Betulinic Acid Analogues.

Huang QX, Chen HF, Luo XR, Zhang YX, Yao X, Zheng X. Huang QX, et al. Curr Med Sci. 2018 Jun;38(3):387-397. doi: 10.1007/s11596-018-1891-4. Epub 2018 Jun 22. Curr Med Sci. 2018. PMID: 30074203 Review.

4

Atomically precise vacancy-assembled quantum antidots.

Fang H, Mahalingam H, Li X, Han X, Qiu Z, Han Y, Noori K, Dulal D, Chen H, Lyu P, Yang T, Li J, Su C, Chen W, Cai Y, Neto AHC, Novoselov KS, Rodin A, Lu J. Fang H, et al. Among authors: chen h. Nat Nanotechnol. 2023 Dec;18(12):1401-1408. doi: 10.1038/s41565-023-01495-z. Epub 2023 Aug 31. Nat Nanotechnol. 2023. PMID: 37653051

5

Exosome-Mediated Drug Delivery for Cell-Free Therapy of Osteoarthritis.

Duan L, Xu X, Xu L, Chen H, Li X, Alahdal M, Xiao Y, Liang Y, Xia J. Duan L, et al. Among authors: chen h. Curr Med Chem. 2021;28(31):6458-6483. doi: 10.2174/0929867327666201118161232. Curr Med Chem. 2021. PMID: 33213308 Review.

6

TSG101: a novel anti-HIV-1 drug target.

Chen H, Liu X, Li Z, Zhan P, De Clercq E. Chen H, et al. Curr Med Chem. 2010;17(8):750-8. doi: 10.2174/092986710790514444. Curr Med Chem. 2010. PMID: 20088757 Review.

7

Graphene-based materials: A new tool to fight against breast cancer.

Zheng J, Meng D, Zheng X, Zhang Y, Chen H. Zheng J, et al. Among authors: chen h. Int J Pharm. 2021 Jun 15;603:120644. doi: 10.1016/j.ijpharm.2021.120644. Epub 2021 May 6. Int J Pharm. 2021. PMID: 33964335 Review.

8

Development of PI3K inhibitors: Advances in clinical trials and new strategies (Review).

Meng D, He W, Zhang Y, Liang Z, Zheng J, Zhang X, Zheng X, Zhan P, Chen H, Li W, Cai L. Meng D, et al. Among authors: chen h. Pharmacol Res. 2021 Nov;173:105900. doi: 10.1016/j.phrs.2021.105900. Epub 2021 Sep 20. Pharmacol Res. 2021. PMID: 34547385 Review.

9

Anticancer activity of oleanolic acid and its derivatives modified at A-ring and C-28 position.

Gao CX, Tang CH, Wu TJ, Hu Y, Peng YL, Liu ML, Liu QW, Chen HF, Yang ZH, Zheng X. Gao CX, et al. J Asian Nat Prod Res. 2023 Jun;25(6):581-594. doi: 10.1080/10286020.2022.2120863. Epub 2022 Sep 24. J Asian Nat Prod Res. 2023. PMID: 36151896 Review.

10

[The databases of transcription factors.].

Chen HF, Wang JK. Chen HF, et al. Yi Chuan. 2010 Oct;32(10):1009-17. doi: 10.3724/sp.j.1005.2010.01009. Yi Chuan. 2010. PMID: 20943488 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year